Piper Jaffray Starts Aptevo Therapeutics (APVO) at Overweight
Get Alerts APVO Hot Sheet
Price: $0.68 --0%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Join SI Premium – FREE
Piper Jaffray earlier initiated coverage on Aptevo Therapeutics (NASDAQ: APVO) with an Overweight rating and a price target of $7.00.
For an analyst ratings summary and ratings history on Aptevo Therapeutics click here. For more ratings news on Aptevo Therapeutics click here.
Shares of Aptevo Therapeutics closed at $2.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singular Research Starts Citizens Inc. (CIA) at Buy-Long Term, 'Proven Distribution Growth'
- Goldman Sachs Resumes JD.com, Inc (JD) at Buy
- Scotiabank Starts Rapid7 (RPD) at Sector Perform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!